SCHEMBL18655365

SCHEMBL18655365

CNc1c2ccccc2nc2c1ccc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.50
KDM1A O60341 7/20 0.47
ATM Q13315 1/20 0.43
NCF1 P14598 1/20 0.43
MAPT P10636 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
NUDT1 P36639 1/20 0.40
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
ELANE P08246 1/20 0.39
HPRT1 P00492 1/20 0.39
POLB P06746 1/20 0.39
RAD52 P43351 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK10 P53779 1/20 0.38
RIPK1 Q13546 1/20 0.38
CTSD P07339 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18650739 0.89 L3MBTL1 (0.47) MAOAKDM1AATMNCF1MAPT
SCHEMBL18655358 0.85 MAOA (0.43) MAOAKDM1AMAPTL3MBTL1KDM4E
SCHEMBL18655357 0.84 MAOA (0.49) MAOAKDM1AMAPTL3MBTL1KDM4E
SCHEMBL18655360 0.83 CCR1 (0.47) KDM1AATMMAPTL3MBTL1KDM4E
SCHEMBL18631798 0.82 POLB (0.49) MAOAMAPTKDM4ELMNAPOLB
SCHEMBL5410460 0.81 KDM1A (0.66) MAOAKDM1AATMMAPTNUDT1
Iodide SCHEMBL17187186 0.79 KDM1A (0.63) MAOAKDM1AATMMAPTNUDT1
SCHEMBL18655362 0.78 KMT2A (0.49) MAOAMAPTKDM4EPOLBKMT2A
SCHEMBL18655356 0.78 LRRK2 (0.47) KDM1AATMMAPTNUDT1KDM4E
SCHEMBL18678491 0.77 MAOA (0.73) MAOAATMMAPTL3MBTL1NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170081351-A1 Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith WAKE FOREST UNIVERSITY 2017-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170081351-A1 Design, Synthesis, and Biological Activity of Platinum-benz[c]acridine Hybrid Agents and Methods Associated Therewith ACR, TP53, MCL1 MAOA 2459/4885KDM1A 3582/4885ATM 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.